clock.bio is a rejuvenation biology company developing therapies to extend human healthspan by reversing cellular aging at the genetic level. Using proprietary CRISPR screens in human induced pluripotent stem cells, the company has mapped over 150 genes in its 'geneAge Atlas of Rejuvenation Factors' and built an AI-powered cell age measurement platform called imAge. Based at the Milner Therapeutics Institute, University of Cambridge, the company raised $5.3M in seed funding in 2024.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2024
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...
